The India over-the-counter pain relievers market was valued at USD 1.23 Billion in 2025 and is expected to grow at a CAGR of 3.20%, reaching USD 1.69 Billion by 2035. The market growth is driven by growing urbanization and rising disposable incomes, which boost OTC product consumption. Expansion of retail pharmacies and online platforms improves accessibility. Additionally, increasing prevalence of lifestyle-related disorders and greater health literacy are expected to support market growth over the forecast period.
Base Year
Historical Period
Forecast Period
The market is experiencing strong growth, driven by rising chronic pain prevalence, increasing consumer health awareness, and expanding access to healthcare, encouraging higher self-medication and over-the-counter product adoption.
The key trends in the market are the growing preference for fast-acting and combination formulations, increased demand for herbal and natural alternatives, and a significant shift toward e-commerce and modern retail channels for convenient product availability.
Leading players in the market are driving growth through strategic product innovations, portfolio diversification, targeted marketing, and robust distribution networks, enabling broader consumer reach and reinforcing market competitiveness across India.
Compound Annual Growth Rate
3.2%
Value in USD Billion
2026-2035
*this image is indicative*
Over-the-counter pain relievers in India are increasingly adopted for the management of common ailments such as headaches, muscular pain, and joint discomfort. Growing consumer preference for self-medication and convenient access to retail and e-commerce platforms has fueled demand. The market is poised to reach USD 1.69 Billion by 2035, driven by heightened health awareness, urbanization, and expansion of pharmaceutical distribution networks. Increasing product variety and the introduction of novel formulations are further boosting market growth, positioning OTC pain relievers as an essential component of accessible healthcare solutions across the country.
Rising Migraine Prevalence to Drive Market Growth in India
The increasing prevalence of migraine in India has emerged as a significant growth driver for the market. According to Shilpi Shukla et al., 2024, migraine affects a substantial portion of the population, particularly in rural areas, with prevalence rates ranging from 14.1% to 25.2%. This high incidence has led to greater self-medication and a rising demand for accessible pain relief solutions. As awareness of migraine management grows alongside healthcare accessibility, the OTC pain relievers market in India is expected to experience steady and sustained growth in the coming years.
Some of the trends in the market include the increasing popularity of sports-endorsed OTC pain relief products and the growing transition of OTRx brands to OTC pain relievers.
Rising Adoption of Sports-Endorsed OTC Pain Relief Solutions to Boost Market Value
The market is witnessing a growing trend of sports-focused brand endorsements, leveraging high-intensity athletics to highlight product efficacy. In August 2025, Nimulid Strong partnered with the Patna Pirates as the official pain relief partner for Pro Kabaddi League Season 12, emphasizing its rapid-action, high-concentration diclofenac formula tailored for athletes’ neck and body strain. Such strategic alignments not only enhance brand visibility but also reinforce product credibility among active consumers, driving wider adoption. This trend is expected to support sustained growth in the Indian market.
Rise in the Availability of OTC Pain Relievers Boosting India Over-the-Counter Pain Relievers Market Value
The shift towards OTC availability in the Indian pain relievers market, as more prescription (Rx) and OTRx brands become directly accessible to consumers, represents a significant trend. This trend reflects growing consumer self-medication habits, heightened health awareness, and demand for convenient pain management solutions. For instance, Crocin’s evolution from a prescription-only medication to a widely accessible OTC product exemplifies this shift. By leveraging consumer education, innovative packaging, and expanded distribution, pharmaceutical companies are enhancing accessibility and trust. This trend is expected to continue, driving sustained market growth.
Oral Formulations to Lead the Market by Route of Administration
The market includes various routes of administration, primarily oral, topical, and parenteral formulations. Among these, oral formulations are expected to lead due to their convenience, widespread use, and strong consumer preference. Products like Crocin Advance, featuring innovative Optizorb technology, begin dissolving within five minutes and provide rapid pain relief. Such advancements enhance absorption and effectiveness, further strengthening the dominance of oral pain relievers in the market.
The key features of the market report comprise clinical trials analysis, patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Bayer Consumer Health in India provides a variety of OTC products, including Saridon® for pain relief and multivitamins like Supradyn®. The company focuses on developing safe, effective, and accessible solutions that meet the needs of Indian consumers. Through product innovation and commitment to health, Bayer continues to strengthen its presence in India’s growing OTC pain relievers market.
Haleon PLC operates in the Indian OTC pain relievers market with its well-known brands Panadol and Voltaren. The company focuses on helping consumers manage pain and inflammation effectively. Leveraging its global expertise, Haleon introduces innovative solutions and strengthens its presence in India, catering to the growing demand for accessible and reliable OTC pain relief products.
Sun Pharmaceutical Industries Ltd is a prominent player in the over the counter (OTC) pain relievers market. The company markets well-known analgesic brands, including Volini, Painamol, and Paduden, alongside other consumer healthcare products. Leveraging its extensive domestic manufacturing facilities and broad distribution network, Sun Pharma provides accessible, high-quality OTC pain relief solutions while continuing to strengthen its presence in India’s growing consumer healthcare segment.
Teva Pharmaceutical Industries Ltd. operates in India through its subsidiary, Teva Pharmaceuticals India Pvt. Ltd., with offices and facilities across the country. The company's consumer healthcare division offers over-the-counter (OTC) products, including Sudocrem® and Infacol®, which are well-known for treating conditions like nappy rash, colic, and minor skin irritations. Teva's involvement in the OTC pain relievers market is underscored by its joint venture with Procter & Gamble, PGT Healthcare, which established a manufacturing plant in Sanand, India, to produce OTC products such as Vicks and Pepto-Bismol.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Boehringer Ingelheim International GmbH, Johnson & Johnson Innovative Medicine, Endo International PLC, Sanofi SA, and Dr. Reddy's Laboratories Ltd.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Drug Type
Market Breakup by Route of Administration
Market Breakup by Distribution Channel
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Type |
|
| Breakup by Route of Administration |
|
| Breakup by Distribution Channel |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share